Belite Bio Inc - ADR
BLTE
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.85B
Close$
$10.51
93.8% downside
Current Fair Value
93.8% downsideOvervalued by 93.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.85 Billion |
|---|---|
| Enterprise Value | $6.85 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.31 |
| Beta | -1.24 |
| Outstanding Shares | 40,182,310 |
Return
| Return on Equity | -13.18% |
|---|---|
| Return on Assets | -12.93% |
| Return on Invested Capital | -15.45% |
Valuation & Multiples
| P/E Ratio | -61.94 |
|---|---|
| PEG | -83.6 |
| Price to Sales | - |
| Price to Book Ratio | 8.88 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -57.13 |
| Enterprise Value to Net Income | -67 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.73
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.79
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.58%▲ 0.71% |
|---|---|
| Total Invested | $1.44B▲ 1.36% |
| Investors Holding | 82▲ 7.00% |
ESG Score
No data